Subjects Connect to electronic resource

Table of Contents “...What Do You Need to Know about the Diagnostic and Statistical Manual (DSM)?; What is Neuropsychological Testing, and is it Ever a Good Idea?; What Kinds of Professional Guidelines Exist for the Diagnosis of ADHD?...”
Connect to electronic resource

Table of Contents “...Detecting Malingering in Forensic Neuropsychological Evaluations in Litigants with Mild Traumatic Brain Injury /...”

Connect to electronic resource

Table of Contents “...[et al.] -- Clinical neuropsychology / Robert J. McCaffrey, Julie K. Lynch, and Holly James Westervelt -- Psychological interventions in health-care settings / Charles F. ...”

Table of Contents “...Carter -- Language and communication in autism / So Hyun Kim, Rhea Paul, Helen Tager-Flusberg, Catherine Lord -- Play development in children with autism spectrum disorders : skills, object play, and interventions / Connie Kasari, Ya-Chih Chang -- Imitation in autism spectrum disorders / Giacomo Vivanti, Antonia Hamilton -- Neuropsychological characteristics of autism spectrum disorders / Katherine D. ...”
Connect to electronic resource

Table of Contents “...Sharing a simple neuropsychological explanation of traumatic memories -- 15. ...”

Table of Contents “...Machine generated contents note: 1.1.Antiquity -- 1.2.Middle Ages -- 1.3.Modern Era -- References -- 2.1.Normal Emotions, Neurobiology and Ethological Considerations -- 2.2.The Conceptualization of Bipolar Disorder -- 2.3.Bipolar Depression -- 2.4.Mania -- 2.5.Hypomania -- 2.6.Mixed States -- 2.7.Psychotic Features -- 2.8.Other Clinical Issues -- 2.9.The Subjective Experience of Manic[—]Depressive Patients -- 2.10.List and Definitions of Symptoms and Signs -- 2.10.1.Mood -- 2.10.2.Psychomotor Disorder -- 2.10.3.Neurocognitive Disorder -- 2.10.4.Thought Disorder -- 2.10.5.Psychotic Features -- 2.10.6.Somatic and Neurovegetative Symptoms -- 2.10.7.Behavioural Disorder -- References -- 3.1.Predominant Polarity -- 3.2.Seasonality -- 3.3.Rapid Cycling -- References -- 4.1.General Neurocognitive Functioning and Intelligence Quotient (IQ) -- 4.2.Psychomotor and Mental Speed -- 4.3.Attention -- 4.4.Learning and Memory -- 4.5.Verbal Skills -- 4.6.Visuospatial Skills -- 4.7.Executive Function -- 4.8.Social Cognition and Theory of Mind (ToM) -- 4.8.1.ToM -- 4.8.2.Emotion Processing -- 4.8.3.Emotional Decision-Making -- 4.8.4.Reviews and Meta-analyses -- 4.9.Clinical Correlations -- 4.9.1.The Effect of Medication -- 4.9.2.The Effect of Psychotic Symptoms -- 4.9.3.The Effect of Mood Symptoms -- 4.9.4.The Effect of Age and Age at Onset and Personal Psychiatric History -- 4.9.5.The Role of Other Clinical Factors -- 4.10.BD-II -- 4.11.Long-Term Development of the Neurocognitive Deficit -- 4.12.Awareness of the Neurocognitive Deficit -- 4.13.Gender and the Neurocognitive Deficit -- 4.14.The Neurocognitive Deficit as an Endophenotype for BD -- 4.14.1.Twin Studies -- 4.14.2.Studies on First-Degree Relatives -- 4.14.3.Studies on Mixed Samples of Relatives -- 4.14.4.Reviews and Meta-analyses -- References -- 5.1.Historical Perspective -- References -- References -- References -- References -- 9.1.Epidemiology -- 9.1.1.Epidemiology of Alcohol Use Disorder -- 9.1.2.Epidemiology of Cannabis Use Disorder -- 9.1.3.Epidemiology of Gambling -- 9.1.4.Epidemiology of Methadone -- 9.1.5.Epidemiology of Cocaine -- 9.1.6.Epidemiology of Opioids -- 9.1.7.Epidemiology of Smoking -- 9.2.Etiopathogenesis of SUD in BD -- 9.2.1.General Causative Factors and Mechanisms -- 9.2.2.Neurobiology -- 9.3.Clinical Issues -- 9.3.1.Clinical Issues Related to Alcohol Use -- 9.3.2.Clinical Issues Related to Cannabis Use -- 9.3.3.Clinical Issues Related to Cocaine Use -- 9.3.4.Clinical Issues Related to Opioid Use -- 9.3.5.Clinical Issues Related to Nicotine Use and Smoking -- 9.3.6.Substance Use and Neurocognitive Disorder -- 9.3.7.Comorbidity -- 9.3.8.Disability -- 9.3.9.Suicidality -- 9.4.Legal Issues -- 9.5.Treatment -- References -- 10.1.Psychiatric Comorbidity -- 10.1.1.Comorbid Anxiety -- 10.1.2.Comorbid Obsessive[—]Compulsive Disorder (OCD) -- 10.1.3.Comorbid Attention Deficit Hyperactivity Disorder (ADHD) -- 10.1.4.Comorbid Complicated Grief (CG) -- 10.1.5.Comorbid Eating Disorders -- 10.1.6.Various Other Comorbid Conditions -- 10.1.7.Comorbid Psychiatric Disorders and BD-II -- 10.2.Medical Comorbidity -- 10.2.1.General Medical Comorbidity -- 10.2.2.Metabolic Syndrome and Related Medical Conditions -- 10.2.3.Comorbid Vascular Disease -- 10.2.4.Comorbid Neurological Conditions -- 10.2.5.Infectious Diseases -- 10.2.6.Cancer -- 10.2.7.Endocrinological Disorders -- 10.2.8.Gastroenterological Disorders -- 10.2.9.Disorders of the Blood -- 10.2.10.Respiratory System Disorders -- 10.2.11.Various Comorbid Medical Disorders -- 10.3.Genetics and Endophenotypes -- References -- 11.1.Classification -- 11.1.1.General Considerations -- 11.1.2.Contemporary Classification Systems -- 11.1.3.Contemporary Classification of BD and Related Disorders -- 11.2.Epidemiology of BD -- 11.2.1.The Amish Study -- 11.2.2.The Epidemiological Catchment Area (ECA) -- 11.2.3.The National Comorbidity Survey (NCS) -- 11.2.4.The Cross-National Collaborative Group (CNCG) -- 11.2.5.Zurich Switzerland -- 11.2.6.Shatin, Hong Kong -- 11.2.7.Nottingham, UK -- 11.2.8.The Netherlands Study -- 11.2.9.The Australian Study -- 11.2.10.The Butajira Study -- 11.2.11.The Merikangas Study -- 11.2.12.Other Smaller Studies -- 11.2.13.Epidemiology of the Bipolar Spectrum -- 11.2.14.Conclusions on Epidemiology -- References -- 12.1.Disability -- 12.1.1.Overview and Definitions -- 12.1.2.Disability in BD Patients -- 12.2.Quality of Life -- 12.3.Caregiver and Family Burden -- 12.3.1.Prevalence of Caregiver Burden -- 12.3.2.Objective Burden -- 12.3.3.Subjective Burden -- 12.3.4.Influence of Sociodemographic Factors on Caregiver Burden -- 12.3.5.Special Topics Related to Caregiver Burden -- 12.3.6.Comparison with Burden Caused by Other Disorders -- 12.3.7.Interventions -- 12.3.8.Caregiver Burden and Patient Outcome -- 12.4.Cost -- 12.5.Stigma -- References -- 13.1.Social Theories -- 13.2.Psychological Theories -- 13.2.1.Aggression-Turned-Inward Model -- 13.2.2.Object Loss -- 13.2.3.Loss of Self-Esteem -- 13.2.4.Cognitive Model -- 13.2.5.Learned Helplessness Model -- 13.2.6.Depression and Reinforcement -- 13.3.Neurobiology of BD -- 13.3.1.Neuroanatomy of BD -- 13.3.2.Functional Studies -- 13.3.3.Neurotransmitters and Receptors -- 13.3.4.Genetic Studies -- References -- 14.1.Introduction -- 14.2.Psychometric Tools -- 14.2.1.Depression Rating Scales -- 14.2.2.Mania Rating Scales -- 14.2.3.Anxiety Rating Scales -- 14.2.4.Psychotic Symptoms Rating Scales -- 14.2.5.Disability and General Assessment -- 14.2.6.Temperament and Personality Inventories -- 14.2.7.Adverse Events Scales -- 14.2.8.Substance Use Scales -- 14.2.9.Other Rating Scales -- 14.3.Neuropsychological Tools -- References -- 15.1.The Concept of Staging -- 15.2.Staging of BD -- 15.2.1.Clinical Determinants of BD Staging -- 15.2.2.Neurobiological Determinants of BD Staging -- 15.2.3.Treatment Data Supporting the Staging Approach -- 15.3.Existing Models for the Staging of BD -- 15.3.1.The Model of Berk -- 15.3.2.The Model of Kapczinski -- 15.3.3.The Model of Post -- 15.3.4.The Model of Cosci and Fava -- 15.3.5.The Model of Frank -- 15.4.The Future of Staging of BD -- References -- 16.1.General Background -- 16.1.1.Lithium -- 16.1.2.Antiepileptics -- 16.1.3.Antipsychotics -- 16.1.4.Antidepressants -- 16.2.Evidence-Based Treatment -- 16.2.1.Acute Mania -- 16.2.2.Acute Bipolar Depression -- 16.2.3.Maintenance Treatment -- 16.2.4.Treatment of Mixed Episodes -- 16.2.5.Treatment of Rapid Cycling Patients -- 16.2.6.Treatment of Special Conditions -- 16.2.7.Cautions for Pharmaceutical Treatment in BD Patients -- 16.2.8.Switching to the Opposite Pole -- References -- 17.1.General Background -- 17.2.Specific Psychotherapies and Psychosocial Interventions -- 17.2.1.Cognitive-Behavioural Therapy (CBT) -- 17.3.Psychoeducation -- 17.4.Interpersonal and Social Rhythm Therapy (IPSRT) -- 17.5.Family Intervention -- 17.6.Intensive Psychosocial Intervention -- 17.7.Cognitive Remediation and Functional Remediation -- 17.8.Mindfulness-Based Interventions -- References -- 18.1.Background -- 18.2.List of Existing Guidelines -- 18.3.Critical Review of the Most Important Guidelines -- 18.3.1.American Psychiatric Association Treatment Guidelines for BD -- 18.3.2.The Canadian Network for Mood and Anxiety Treatments and International Society on Bipolar Disorder Guidelines (CANMAT/ISBD) -- 18.3.3.The Texas Medication Algorithm Project (TMAP) for the Treatment of BD -- 18.3.4.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of BD -- 18.3.5.British Association for Psychopharmacology (BAP) -- 18.3.6.The UK National Institute of Clinical Excellence (NICE) Treatment Guidelines for BD -- 18.4.Critical View of Treatment Guidelines for BD -- References -- 19.1.Gender -- 19.2.Suicidality -- 19.3.Paediatric BD -- 19.3.1.Epidemiology of Paediatric BD -- 19.3.2.Clinical Features of Paediatric BD -- 19.3.3.Aetiopathogenesis of Paediatric BD -- 19.3.4.Treatment of Paediatric BD -- 19.4.Geriatric BD -- 19.4.1.Epidemiology of Geriatric BD -- 19.4.2.Clinical Features of Geriatric BD -- 19.4.3.Neurobiology of Geriatric BD -- 19.4.4.Treatment of Geriatric BD -- References....”
Connect to electronic resource

Table of Contents “..."Optimal Practice" Clinical Neuropsychology: A Cautionary Tale and Revisionist Proto-Model /...”
Publisher description
Table of contents only

Table of Contents “...On Bridging the Gap between Social-Personality Psychology and Neuropsychology /...”

Table of Contents “...National Cancer Institute -- National Children's Study -- National Health and Nutrition Examination Survey (NHANES) -- National Health Interview Survey -- National Heart, Lung, and Blood Institute -- National Institute of Child Health and Human Development -- National Institute of Diabetes and Digestive and Kidney Diseases -- National Institute of Mental Health -- National Institute of Nursing Research -- National Institute on Aging -- National Institute on Alcohol Abuse and Alcoholism -- National Institutes of Health -- Natural Killer Cell Activity -- Needle Exchange Programs -- Negative Affect -- Negative Affectivity -- Negative Thoughts -- Nested Study -- Neuroendocrine Activation -- Neuroendocrine Theory of Aging -- Neurogenomics -- Neuroimaging -- Neuroimmunology -- Neuroimmunomodulation -- Neurological -- Neuromuscular Diseases -- Neuron -- Neuropeptide Y (NPY) -- Neuropsychology -- Neurotensin -- Neurotic Anger, Subcategory of Anger -- Neuroticism -- Neurotransmitter -- Nicotine -- Nicotine Patch -- Night-Shift Workers and Health -- Nitric Oxide Synthase (NOS) -- Nocebo and Nocebo Effect -- Nonexperimental Designs -- Non-REM Sleep -- Nonverbal Communication -- Norepinephrine/Noradrenaline -- Norms -- Nurses' Health Study -- Nutrition -- Nutrition Data System for Research (NDSR) -- Nutritional Supplements....”
Connect to electronic resource